Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer-the Experience of a Tertiary Cancer Center.
Căinap C, Bochiş OV, Vlad C, Popita R, Achimaş-Cadariu P, Havasi A, Vidrean A, Dranca A, Piciu A, Constantin AM, Tat T, Dana M, Crişan O, Cioban CV, Bălăcescu O, Coza O, Bălăcescu L, Marta MM, Bota M, Căinap S.
Căinap C, et al. Among authors: vlad c.
Front Pharmacol. 2021 Mar 11;12:487316. doi: 10.3389/fphar.2021.487316. eCollection 2021.
Front Pharmacol. 2021.
PMID: 33776758
Free PMC article.